This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04325/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/drug/DB04325/identifier/drugbank/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04325/identifier/chebi/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04325/identifier/pdb/
n7http://linked.opendata.cz/resource/drugbank/drug/DB04325/identifier/kegg-compound/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04325/identifier/pubchem-compound/

Statements

Subject Item
n2:DB04325
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n11:DB04325 n15:DB04325
dcterms:title
2-Phenylethylamine
adms:identifier
n6:DB04325 n7:C05332 n8:18397 n9:46507825 n12:PEA n13:448751
n3:IUPAC-Name
n4:271B4FBA-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4FC0-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4FBF-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4FBC-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4FBD-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4FBE-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4FB8-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4FD1-363D-11E5-9242-09173F13E4C5 n4:271B4FB6-363D-11E5-9242-09173F13E4C5 n4:271B4FB9-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4FB7-363D-11E5-9242-09173F13E4C5
n3:pKa
n4:271B4FD2-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4FC6-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4FC7-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4FC1-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4FC2-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4FC4-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4FC3-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4FC5-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
64-04-0
n3:Bioavailability
n4:271B4FCB-363D-11E5-9242-09173F13E4C5
n3:Boiling-Point
n4:271B4FD0-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4FCD-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4FCE-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B4FCF-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4FCA-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4FC9-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4FCC-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4FBB-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4FC8-363D-11E5-9242-09173F13E4C5